Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Lidds AB

LIDDS
Current price
0.13 SEK -0.01 SEK (-7.09%)
Last closed 0.14 SEK
ISIN SE0001958612
Sector Healthcare
Industry Biotechnology
Exchange Stockholm Exchange
Capitalization 19 249 139 SEK
Yield for 12 month -49.62 %
1Y
3Y
5Y
10Y
15Y
LIDDS
21.11.2021 - 28.11.2021

LIDDS AB (publ), a drug delivery company, develops pharmaceutical products based on its NanoZolid proprietary technology for the treatment of cancer and other diseases in Sweden. The company's oncology pipeline in clinical development includes Liproca Depot, a NanoZolid-formulated 2-hydroxyltutamide (2-HOF), which is an anti-androgen drug that binds and blocks androgen receptors; Nanodotax, a NanoZolid-formulated docetaxel, which is a chemotherapy medication that is approved for various oncological conditions, such as breast cancer, head and neck cancer, and prostate cancer; and Nanoimod, a NanoZolid-formulated agatolimod, which is a toll-like receptor 9 (TLR9) agonist. The company was founded in 2003 and is based in Uppsala, Sweden. Address: Virdings allé 32B, Uppsala, Sweden, 754 50

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

43.72 SEK

P/E ratio

Dividend Yield

Current Year

-109 274 SEK

Last Year

+1 875 474 SEK

Current Quarter

Last Quarter

+22 845 SEK

Current Year

-471 847 SEK

Last Year

-36 376 948 SEK

Current Quarter

-4 972 SEK

Last Quarter

-573 171 SEK

Key Figures LIDDS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -25 466 840 SEK
Operating Margin TTM 47800 %
PE Ratio
Return On Assets TTM -61.89 %
PEG Ratio
Return On Equity TTM -114.25 %
Wall Street Target Price 43.72 SEK
Revenue TTM 16 887 SEK
Book Value 0.057 SEK
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 175.8 %
Dividend Yield
Gross Profit TTM -20 682 809 SEK
Earnings per share -0.37 SEK
Diluted Eps TTM -0.37 SEK
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics LIDDS

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History LIDDS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 326:303
Payout Ratio
Last Split Date 17.01.2023
Dividend Date

Stock Valuation LIDDS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 8.9624
Price Sales TTM 1139.8676
Enterprise Value EBITDA -1.085
Price Book MRQ 1.8732

Financials LIDDS

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators LIDDS

For 52 weeks

0.099 SEK 0.37 SEK
50 Day MA 0.13 SEK
Shares Short Prior Month
200 Day MA 0.16 SEK
Short Ratio
Shares Short
Short Percent